제품정보 원하는 정보를 직접 검색하실 수 있습니다.

HOME>Product>Product List
innovation leader

XALOSTPLUS OPHTHALMIC SOLUTION

  • pic1
  • pic2
  • Latanoprost

    제품상세설명
    DivisionSpecialty drugs
    SymptomsAntiglaucoma Agents
    Insurance code650100951

기본정보

복약안내

주의사항

전체정보

MAIN INGREDIENT

Per 1mL
Latanoprost (In-house). . . . . . . . . . . .50μg
Timolol Maleate (EP). . . . . . . . . . . .6.83mg
(as Timolol 5.00mg)
Preservative: Benzalkonium Chloride . . . . . . . . . . .0.2mg

APPEARANCE

Colorless, transparent eye drop solution in a transparent plastic bottle

EFFICACY

Reduction of intraocular pressure of the patients with open-angle glaucoma or with ocular hypertension who are insufficiently responsive to topical beta blockers

Adults: Apply 1 drop in the affected eye(s) once daily in the morning.
The dosage of the eye drops should not exceed once daily since it has been shown that more frequent administration decreases the intraocular pressure lowering effect. If one dose is missed, treatment should continue with the next dose as normal. When using in combination with any other eye drops, admin eye drops at least interval 5 minutes. Contact lenses should be removed before instillation of the eye drops and may be reinserted after 15 minutes.
No data are available for children and youth.
When using nasolacrimal occlusion or closing the eyelids for 2 minutes, the systemic absorption is reduced. This may result in a decrease in systemic side effects and an increase in local activity.

Tightly closed, protected from light, keep at 2~8℃

STRONG POINT

XALOSTPLUS OPHTHALMIC SOLUTION is a drug combination containing two active ingredients: latanoprost that increases aqueous humor outflow and timolol maleate that reduces aqueous humor production. Accordingly Xalostplus Ophthalmic Solution leads to additive intraocular pressure-lowering effects.

MAIN INGREDIENT

Per 1mL
Latanoprost (In-house). . . . . . . . . . . .50μg
Timolol Maleate (EP). . . . . . . . . . . .6.83mg
(as Timolol 5.00mg)
Preservative: Benzalkonium Chloride . . . . . . . . . . .0.2mg

APPEARANCE

Colorless, transparent eye drop solution in a transparent plastic bottle

EFFICACY

Reduction of intraocular pressure of the patients with open-angle glaucoma or with ocular hypertension who are insufficiently responsive to topical beta blockers

MEDICATION INFORMATION

Adults: Apply 1 drop in the affected eye(s) once daily in the morning.
The dosage of the eye drops should not exceed once daily since it has been shown that more frequent administration decreases the intraocular pressure lowering effect. If one dose is missed, treatment should continue with the next dose as normal. When using in combination with any other eye drops, admin eye drops at least interval 5 minutes. Contact lenses should be removed before instillation of the eye drops and may be reinserted after 15 minutes.
No data are available for children and youth.
When using nasolacrimal occlusion or closing the eyelids for 2 minutes, the systemic absorption is reduced. This may result in a decrease in systemic side effects and an increase in local activity.

NOTES

Tightly closed, protected from light, keep at 2~8℃